Results 221 to 230 of about 143,676 (242)
Some of the next articles are maybe not open access.
The Lancet, 1996
SIR—Since only opinions contrary to thrombolysis seem lately to be heard, we feel it is useful to express a critical point of view, starting from Bignall’s report on the 4th International Symposium on Thrombolytic Therapy in Acute Ischaemic Stroke. As you may know, the Acute Stroke Pooling Project did a meta-analysis of the streptokinase trials, so ...
FIESCHI, Cesare, TONI, Danilo
openaire +4 more sources
SIR—Since only opinions contrary to thrombolysis seem lately to be heard, we feel it is useful to express a critical point of view, starting from Bignall’s report on the 4th International Symposium on Thrombolytic Therapy in Acute Ischaemic Stroke. As you may know, the Acute Stroke Pooling Project did a meta-analysis of the streptokinase trials, so ...
FIESCHI, Cesare, TONI, Danilo
openaire +4 more sources
Thrombolysis for Pulmonary Embolism
New England Journal of Medicine, 1991The primary therapy for acute pulmonary embolism is anticoagulation with heparin and warfarin to prevent additional thromboembolism.
openaire +4 more sources
Current Opinion in Neurology, 2003
Stroke thrombolysis is in the process of moving from academic centers into community-based standard therapy in experienced centers. Recently published data on patient selection, imaging and other technical or organizational advances are reviewed in order to improve the safety and efficacy of stroke thrombolysis and identify areas in which more study is
Markku Kaste, Perttu J. Lindsberg
openaire +4 more sources
Stroke thrombolysis is in the process of moving from academic centers into community-based standard therapy in experienced centers. Recently published data on patient selection, imaging and other technical or organizational advances are reviewed in order to improve the safety and efficacy of stroke thrombolysis and identify areas in which more study is
Markku Kaste, Perttu J. Lindsberg
openaire +4 more sources
Unstable angina and thrombolysis
Chest, 1990Unstable angina occurs in a heterogeneous population of patients. In the subset of patients with recent rest angina, both angiographic and angioscopic studies have suggested that coronary artery thrombus is often present and serves as a predictor of subsequent adverse clinical events, including recurrent angina, myocardial infarction, the need for ...
openaire +3 more sources
Medical Journal of Australia, 2010
The clinical applicability of new therapies may be exaggerated bythe Hawthorne effect of clinical trials. The European Safe Implemen-tation of Thrombolysis in Stroke Monitoring Study (SITS-MOST)registry — a mandated requirement of European drug licensingauthorities — was established to monitor thrombolysis in day-to-dayclinical practice.
Mark Fitzgerald +3 more
openaire +2 more sources
The clinical applicability of new therapies may be exaggerated bythe Hawthorne effect of clinical trials. The European Safe Implemen-tation of Thrombolysis in Stroke Monitoring Study (SITS-MOST)registry — a mandated requirement of European drug licensingauthorities — was established to monitor thrombolysis in day-to-dayclinical practice.
Mark Fitzgerald +3 more
openaire +2 more sources
Archives of Neurology, 1996
Thrombolytictherapy for stroke signals a breakthrough, through clots and nihilistic attitudes. Although a systematic approach to stroke care as exemplified by stroke units has been shown to improve outcomes, 1 recombinant tissue-type plasminogen activator (rt-PA) is the first drug to make a demonstrable difference to stroke.
openaire +5 more sources
Thrombolytictherapy for stroke signals a breakthrough, through clots and nihilistic attitudes. Although a systematic approach to stroke care as exemplified by stroke units has been shown to improve outcomes, 1 recombinant tissue-type plasminogen activator (rt-PA) is the first drug to make a demonstrable difference to stroke.
openaire +5 more sources
Australian and New Zealand Journal of Medicine, 1993
Abstract:Since 20% of patients with myocardial infarction (MI) have had a previous infarction, and reinfarction within one year after infarction occurs in 9% of cases, it is important to clarify the role of repeat thrombolysis.After streptokinase (SK) administration, IgG antibodies rise to a peak at two weeks and slowly fall over the next 12 months ...
openaire +2 more sources
Abstract:Since 20% of patients with myocardial infarction (MI) have had a previous infarction, and reinfarction within one year after infarction occurs in 9% of cases, it is important to clarify the role of repeat thrombolysis.After streptokinase (SK) administration, IgG antibodies rise to a peak at two weeks and slowly fall over the next 12 months ...
openaire +2 more sources